Table 1.
Baseline characteristics for all patients.
| All n = 134 | Left sided resection n = 80 | Right sided resection n = 54 | p-value | |
|---|---|---|---|---|
| Sex, n (%) | ||||
| Male | 62 (46.3) | 40 (50.0) | 22 (40.7) | 0.07 |
| Female | 72 (53.7) | 40 (50.0) | 32 (59.3) | 0.07 |
| Age, year, mean (SD) | 67 (8.9) | 66 (8.7) | 69 (9.0) | 0.06 |
| Overall stage, n (%) | ||||
| 1 | 38 (28.4) | 21 (26.3) | 17 (31.5) | 0.52 |
| 2a | 51 (38.1) | 29 (36.3) | 22 (40.7) | 0.60 |
| 2b | 5 (3.7) | 3 (3.8) | 2 (3.7) | 0.99 |
| 3a | 12 (9.0) | 5 (6.3) | 7 13.0) | 0.21 |
| 3b | 28 (20.9) | 22 (27.5) | 6 (11.1) | 0.01 |
| ECOG performance status, n (%) | ||||
| 0 | 111 (82.8) | 70 (87.5) | 41 (75.9) | 0.10 |
| 1 | 17 (12.7) | 9 (11.3) | 8 (14.8) | 0.56 |
| 2 | 6 (4.5) | 1 (1.3) | 5 (9.3) | 0.06 |
| Anthropometrics, mean (SD) | ||||
| Weight, kg | 78.4 (15.7) | 79.6 (15.8) | 76.6 (15.6) | 0.29 |
| Height, cm | 172.5 (9.8) | 172.4 (9.8) | 172.6 (9.9) | 0.91 |
| BMI, kg/m2 | 26.3 (4.6) | 26.8 (4.8) | 25.6 (4.2) | 0.16 |
| Smoking, n (%) | ||||
| Never | 64 (47.8) | 40 (50.0) | 24 (44.4) | 0.53 |
| Former | 51 (38.1) | 31 (38.8) | 20 (37.0) | 0.84 |
| Current | 14 (10.4) | 5 (6.3) | 9 (16.7) | 0.08 |
| Not known | 5 (3.7) | 4 (5.0) | 1 (1.9) | 0.50 |
| Alcohol, n (%) | ||||
| Never | 32 (23.9) | 21 (26.3) | 11 (20.4) | 0.43 |
| Normal | 78 (58.2) | 45 (56.3) | 33 (61.1) | 0.58 |
| Overuse | 20 (14.9) | 11 (13.8) | 9 (16.7) | 0.65 |
| Previous overuse | 1 (0.7) | 1 (1.3) | 0 (0.0) | 0.32 |
| Not known | 3 (2.2) | 2 (2.5) | 1 (1.9) | 0.8 |
| Comorbidities, n (%) | ||||
| Hypertension | 44 (32.8) | 25 (31.3) | 19 (35.2) | 0.64 |
| Hyperlipidemia | 29 (21.6) | 16 (20.0) | 13 (24.1) | 0.58 |
| COPD | 10 (7.5) | 5 (6.3) | 5 (9.3) | 0.53 |
| Cardiovascular disease | 8 (6.0) | 4 (5.0) | 4 (7.4) | 0.58 |
| Others | 3 (2.2) | 2 (3) | 1 (1.9) | 0.8 |
| Pharmacological treatment, n (%) | ||||
| Prednisolone | 4 (3.0) | 2 (3.0) | 2 (3.7) | 0.70 |
| Antihypertensive medication | 89 (66.4) | 51 (63.8) | 38 (70.4) | 0.43 |
| Biochemical values, median (range) | ||||
| IL6, ng/L | 2.2 (0.6–71.9) | 2.0 (0.6–59.6) | 2.4 (0.9–71.9) | 0.47 |
| CRP, mg/L | 1.0 (0.0–76.0) | 0.8 (0.0–76.0) | 1.0 (0.0–51.9) | 0.86 |